Aptose Biosciences Stock Performance
APTO Stock | USD 1.50 0.10 6.25% |
The firm shows a Beta (market volatility) of 0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Aptose Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Aptose Biosciences is expected to be smaller as well. Aptose Biosciences has an expected return of -0.78%. Please make sure to confirm Aptose Biosciences treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Aptose Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Low | High |
Very Weak
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:12 | Last Split Date 2014-10-06 |
1 | Aptose Biosciences Inc Stock What Does the Chart Say Tuesday - InvestorsObserver | 01/09/2024 |
2 | HANMI FILES EARLY WARNING REPORT IN RESPECT OF APTOSE BIOSCIENCES INC. | 02/01/2024 |
3 | Acquisition by William Rice of 70000 shares of Aptose Biosciences subject to Rule 16b-3 | 02/07/2024 |
4 | Closing Bell Aptose Biosciences Inc down on Tuesday - Barchart | 02/20/2024 |
5 | Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024 | 03/18/2024 |
6 | Aptose Biosciences Inc. Receives Average Recommendation of Buy from Brokerages - Defense World | 03/22/2024 |
7 | Aptose Biosciences Inc. Q4 2023 Earnings Call Transcript | 03/27/2024 |
Begin Period Cash Flow | 37 M |
Aptose |
Aptose Biosciences Relative Risk vs. Return Landscape
If you would invest 254.00 in Aptose Biosciences on December 29, 2023 and sell it today you would lose (104.00) from holding Aptose Biosciences or give up 40.94% of portfolio value over 90 days. Aptose Biosciences is currently does not generate positive expected returns and assumes 3.9757% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Aptose, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Aptose Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptose Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aptose Biosciences, and traders can use it to determine the average amount a Aptose Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1968
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | APTO |
Estimated Market Risk
3.98 actual daily | 35 65% of assets are more volatile |
Expected Return
-0.78 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aptose Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptose Biosciences by adding Aptose Biosciences to a well-diversified portfolio.
Aptose Biosciences Fundamentals Growth
Aptose Stock prices reflect investors' perceptions of the future prospects and financial health of Aptose Biosciences, and Aptose Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aptose Stock performance.
Return On Equity | -2.94 | ||||
Return On Asset | -1.02 | ||||
Current Valuation | 8.01 M | ||||
Shares Outstanding | 15.71 M | ||||
Price To Earning | (1.80) X | ||||
Price To Book | 3.21 X | ||||
EBITDA | (51.21 M) | ||||
Net Income | (51.21 M) | ||||
Cash Per Share | 0.68 X | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 6.89 X | ||||
Cash Flow From Operations | (47.09 M) | ||||
Earnings Per Share | (7.72) X | ||||
Total Asset | 12.99 M | ||||
Retained Earnings | (464.33 M) | ||||
Current Asset | 14.98 M | ||||
About Aptose Biosciences Performance
To evaluate Aptose Biosciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Aptose Biosciences generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Aptose Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Aptose Biosciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Aptose's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for 2024 | ||
Return On Capital Employed | 22.46 | 23.58 | |
Return On Assets | (3.94) | (3.75) | |
Return On Equity | 17.65 | 18.53 |
Things to note about Aptose Biosciences performance evaluation
Checking the ongoing alerts about Aptose Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aptose Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Aptose Biosciences generated a negative expected return over the last 90 days | |
Aptose Biosciences may become a speculative penny stock | |
Aptose Biosciences has high historical volatility and very poor performance | |
Aptose Biosciences has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (51.21 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Aptose Biosciences currently holds about 62.41 M in cash with (47.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68. | |
Roughly 20.0% of the company shares are held by company insiders | |
Latest headline from finance.yahoo.com: Aptose Biosciences Inc. Q4 2023 Earnings Call Transcript |
- Analyzing Aptose Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aptose Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Aptose Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aptose Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aptose Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aptose Biosciences' stock. These opinions can provide insight into Aptose Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Aptose Stock analysis
When running Aptose Biosciences' price analysis, check to measure Aptose Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptose Biosciences is operating at the current time. Most of Aptose Biosciences' value examination focuses on studying past and present price action to predict the probability of Aptose Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptose Biosciences' price. Additionally, you may evaluate how the addition of Aptose Biosciences to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Aptose Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.72) | Return On Assets (1.02) | Return On Equity (2.94) |
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.